Process Optimization of Ultrasonic-Assisted Extraction and Resin Purification of Flavonoids from Eucommia ulmoides Leaves and Their Antioxidant Properties In Vitro
In this study, an orthogonal array design was employed to optimize total flavonoid extraction conditions. The results showed that the optimal conditions were an ethanol concentration of 70%, an ultrasonic power of 250 W, a solid–liquid ratio of 1:30 g/mL, and an ultrasonic time of 25 min. Under these optimal extraction conditions, the total flavonoid yield was 169.3 mg/g plant material. The purification effects of LX-38, LX-60, LS-46, LS-306, XDA-8, AB-8, and D101 macroporous resins on the total flavonoids of Eucommia ulmoides leaves were also investigated. The parameters of the process using XDA-8 macroporous resin for the purification of the crude extract of total flavonoids from Eucommia ulmoides leaves were investigated. The adsorption conditions of the XDA-8 resin consisted of an initial sample concentration of 2.0 mg/mL, a sample pH value of 5.0, an adsorption flow rate of 1.5 mL/min, and a temperature of 25 °C. The desorption conditions of the XDA-8 resin consisted of 60% ethanol used as a desorption solution and a 2.0 mL/min desorption flow rate of the eluent. The total flavonoids from the Eucommia ulmoides leaves were purified under these conditions, and, afterward, the flavonoid content was 51.5%. The main components of the purified flavonoids from the Eucommia ulmoides leaves were isolated using high-performance liquid chromatography (HPLC), and they included chlorogenic acid, rutin, isoquercetin, kaempferol-3-O-rutinoside, quercetin 3-rhamnoside, hyperoside, and quercetin. The antioxidant activities were measured, and those of the purified total flavonoids from the Eucommia ulmoides leaves were higher than those of dibutylhydroxytoluene (BHT) and lower than those of ascorbic acid (Vc). Additionally, the purified total flavonoids from the Eucommia ulmoides leaves exhibited significant antioxidant activities.
Authors
- Jungang Wang (ORCID: https://orcid.org/0000-0002-5447-5488)
- Liying Tang (ORCID: https://orcid.org/0000-0002-9887-2135)
- Jia Li
Institutions
- China National Pharmaceutical Group Corporation (China) (CN)
- Bozhou People's Hospital (CN)
Publication Details
- Journal
- Processes
- Published
- 2025-06-16
- DOI
- https://doi.org/10.3390/pr13061905
- Citations
- 3
- Primary Topic
- Phytochemicals and Antioxidant Activities
- Type
- article
- Field-Weighted Citation Impact
- 2.32